Full metadata record
DC FieldValueLanguage
dc.creatorUnzu, C. (Carmen)-
dc.creatorSampedro, A. (Ana)-
dc.creatorMauleon, I. (Itsaso)-
dc.creatorVanrell, L. (Lucía)-
dc.creatorDubrot, J. (Juan)-
dc.creatorEnriquez-de-Salamanca, R. (Rafael)-
dc.creatorGonzález-Aseguinolaza, G. (Gloria)-
dc.creatorMelero, I. (Ignacio)-
dc.creatorPrieto, J. (Jesús)-
dc.creatorFontanellas-Romá, A. (Antonio)-
dc.date.accessioned2012-04-26T08:51:15Z-
dc.date.available2012-04-26T08:51:15Z-
dc.date.issued2010-
dc.identifier.citationUnzu C, Sampedro A, Mauleon I, Vanrell L, Dubrot J, de Salamanca RE, et al. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria. J Hepatol 2010 Mar;52(3):417-424.es_ES
dc.identifier.issn1600-0641-
dc.identifier.urihttps://hdl.handle.net/10171/21803-
dc.description.abstractBACKGROUND & AIMS: Acute intermittent porphyria (AIP) is characterized by hepatic porphobilinogen deaminase (PBGD) deficiency resulting in a marked overproduction of presumably toxic porphyrin precursors. Our study aimed to assess the protective effects of bone marrow transplantation or PBGD gene transfer into the liver against phenotypic manifestations of acute porphyria attack induced in an AIP murine model. METHODS: Lethally irradiated AIP mice were intravenously injected with 5x10(6) nucleated bone marrow cells from wild type or AIP donor mice. To achieve liver gene transfer, AIP mice received via hydrodynamic injection plasmids expressing human PBGD or luciferase, driven by a liver-specific promoter. RESULTS: Erythrocyte PBGD activity increased 2.4-fold in AIP mice receiving bone marrow cells from normal animals. Nevertheless, phenobarbital administration in these mice reproduced key features of acute attacks, such as massively increased urinary porphyrin precursor excretion and decreased motor coordination. Hepatic PBGD activity increased 2.2-fold after hydrodynamic injection of therapeutic plasmid. Mice injected with the luciferase control plasmid showed a high excretion of porphyrin precursors after phenobarbital administration whereas just a small increase was observed in AIP mice injected with the PBGD plasmid. Furthermore, motor disturbance was almost completely abolished in AIP mice treated with the therapeutic plasmid. CONCLUSIONS: PBGD deficiency in erythroid tissue is not associated with phenotypic manifestations of acute porphyria. In contrast, PBGD over-expression in hepatocytes, albeit in a low proportion, reduced precursor accumulation, which is the hallmark of acute porphyric attacks. Liver-directed gene therapy might offer an alternative to liver transplantation applicable in patients with severe and recurrent manifestations.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/closedAccess-
dc.subjectAcute intermittent porphyriaes_ES
dc.subjectAcute attackes_ES
dc.subjectPorphyrin precursor excretiones_ES
dc.subjectMotor coordinationes_ES
dc.subjectBone marrow transplantes_ES
dc.subjectLiver gene transferes_ES
dc.titlePorphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyriaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttp://www.sciencedirect.com/science/article/pii/S016882780900587Xes_ES
dc.type.driverinfo:eu-repo/semantics/articlees_ES

Files in This Item:
There are no files associated with this item.


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.